Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02451397
Other study ID # OPLA_Dr.Tang
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 2012
Est. completion date December 2020

Study information

Verified date January 2021
Source Shanghai Tongji Hospital, Tongji University School of Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

A large-scale, community-based, cross-sectional study was conducted to evaluate the extent to which lifestyle was associated with osteoporosis among the Chinese population by using self-reported questionnaire methods.


Description:

A large-scale, community-based, cross-sectional study was conducted to evaluate the extent to which lifestyle was associated with osteoporosis among the Chinese population by using self-reported questionnaire methods. More than 3000 participants were recruited in communities in Shanghai. Data involved in demographic information, lifestyle, dietary habits, medical history and clinical biomarkers were collected. Every participants were measured bone mineral density (BMD g/cm2) at calcaneus by standardized quantitative ultrasound (QUS, Hologic Inc., Bedford, MA, USA) utilizing T-scores based on WHO criteria. A standard statistical analysis including univariate and multiple variables regression analysis to explore the risk or preventive factors involved in Chinese lifestyle associated with osteoporosis.


Recruitment information / eligibility

Status Completed
Enrollment 3100
Est. completion date December 2020
Est. primary completion date August 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 30 Years to 90 Years
Eligibility Inclusion Criteria: - Participants aged 30-90 years were recruited from rural and urban communities in Shanghai. Exclusion Criteria: - Some participants with chronic diseases and conditions that might potentially affect bone mass, structure, or metabolism were excluded. Briefly, the exclusion criteria were as follows: a history of 1. serious residual effects of cerebral vascular disease; 2. serious chronic renal disease (Glomerular filtration rate - GFR < 30 mL/min/1.73m2); 3. serious chronic liver disease or alcoholism; 4. significant chronic lung disease; 5. corticosteroid therapy at pharmacologic levels; 6. evidence of other metabolic or inherited bone disease, such as hyper- or hypoparathyroidism, Paget disease, osteomalacia, or osteogenesis imperfecta; 7. recent (within the past year) major gastrointestinal disease, such as peptic ulcer, malabsorption, chronic ulcerative colitis, regional enteritis, or significant chronic diarrhea; 8. Cushing syndrome; 9. hyperthyroidism; and 10. any neurologic or musculoskeletal condition that would be a non-genetic cause of low bone mass.

Study Design


Related Conditions & MeSH terms

  • Osteoporosis
  • Osteoporosis of Disuse With Current Pathological Fracture

Locations

Country Name City State
China Huasha Hospital Shanghai Shanghai
China Huashan Hospital Shanghai Shanghai

Sponsors (2)

Lead Sponsor Collaborator
Shanghai Tongji Hospital, Tongji University School of Medicine Huashan Hospital

Country where clinical trial is conducted

China, 

References & Publications (3)

Tang ZH, Wang L, Zeng F, Li Z, Yu X, Zhang K, Zhou L. Bayesian estimation of cardiovascular autonomic neuropathy diagnostic test based on short-term heart rate variability without a gold standard. BMJ Open. 2014 Oct 6;4(9):e005096. doi: 10.1136/bmjopen-2014-005096. — View Citation

Tang ZH, Xiao P, Lei SF, Deng FY, Zhao LJ, Deng HY, Tan LJ, Shen H, Xiong DH, Recker RR, Deng HW. A bivariate whole-genome linkage scan suggests several shared genomic regions for obesity and osteoporosis. J Clin Endocrinol Metab. 2007 Jul;92(7):2751-7. Epub 2007 May 1. — View Citation

Tang ZH, Zeng F, Li Z, Zhou L. Association and predictive value analysis for resting heart rate and diabetes mellitus on cardiovascular autonomic neuropathy in general population. J Diabetes Res. 2014;2014:215473. doi: 10.1155/2014/215473. Epub 2014 Mar 18. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary osteoporosis accessed by Bone Mass Density (BMD) The bone mineral density (BMD g/cm2) was measured at calcaneus by standardized quantitative ultrasound (QUS, Hologic Inc., Bedford, MA, USA) utilizing T-scores based on WHO criteria, which were obtained from the automated equipment. T-score refers to the ratio between patient's BMD and that of young adult population of same sex and ethnicity. T-score of > -1 was taken as normal, between -1 and -2.5 osteopenic and < -2.5 as osteoporotic. participants will be measured for the duration of outpatient stay, an expected average of 2 weeks